We assessed the biological activity of a crude extract, a mixture of several fractions, and a pure compound obtained from Piper ovatum Vahl against promastigote and amastigote forms of Leishmania amazonensis. The medicinal plant P. ovatum is used popularly as an anesthetic and anti-inflammatory. This study included the extraction process and bioassay-guided fractionation by the adsorption chromatography and Sephadex LH-20 method. A progressive increase in the antileishmanial effect was observed in the course of fractionation. The 50% inhibitory concentration (IC 50 ) for dichloromethane-ethyl acetate (1:1 v/v) fraction was 2.1 µg/ml and 24 µg/ml; mixture of piperovatine: piperlongumune (2:3) 0.9 µg/ml and 24 µg/ml; piperovatine (1) 9.5 µg/ml and 10 µg/ml; and piperlonguminine (2) 2.5 µg/ml and 9.0 µg/ml, for promastigote and amastigote forms, respectively. Cytotoxicity analysis indicated that these toxic concentrations were much higher for J774G8 macrophages and Vero cells than for the protozoans. The mixture of piperovatine: piperlongumune (2:3) showed important antiprotozoal activity against the amastigote and promastigote forms of L. amazonensis, and it produced morphological changes in promastigotes and amastigotes at 0.9 mg/ml and 24 mg/ml (50% growth inhibition concentration), respectively, including intense cytoplasmic vacuolization, mitochondrial swelling, and mitochondrial damage, as revealed by transmission electron microscopy.
INTRODUCTION
Leishmaniasis is an insect-borne protozoan infection that affects an estimated 12 million people worldwide, causing significant morbidity and mortality in Africa, Asia and Latin America (WHO 2001) . Pentavalent antimonials are the first-line treatments, but their irregular effectiveness makes them sometimes disappointing because of antimonial resistance and relapse following Amphotericin B therapy. Second-line drugs, such as Amphotericin B, are more toxic, and Amphotericin B's lipid formulation is too expensive for routine use in underdeveloped countries (Murray 2001) . There is at present no effective vaccine for humans (Handman 2001) . Several new alkylphosphocholine derivatives with amide or ester bonds in the alkyl chain have been
